Biotech Company Inks Deal for HQ Move to 1 WTC

January 6th 2016

Progenics Pharmaceuticals, a biotech company specializing in cancer treatment, is taking 26,500-square-foot digs at 1 World Trade Center.

The publically traded company, which produces medicine and technology for prostate cancer patients, will be in pre-built space on the 47th floor of the 3-million-square-foot tower, according to a press release from the landlords, the Durst Organization and the Port Authority of New York & New Jersey

 

Click here to read the full article

Email Broker

Cushman & Wakefield ®

Connect